Y030-5022 Screening compound: 2-bromo-N-(6-methoxy-1,3-benzothiazol-2-yl)benzamide

Y030-5022 Screening compound: 2-bromo-N-(6-methoxy-1,3-benzothiazol-2-yl)benzamide
Y030-5022 Screening compound: 2-bromo-N-(6-methoxy-1,3-benzothiazol-2-yl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y030-5022
2-bromo-N-(6-methoxy-1,3-benzothiazol-2-yl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y030-5022

Molecular Formula

C15H11BrN2O2S (C15 H11 BrN2 O2 S)

Compound Name

2-bromo-N-(6-methoxy-1,3-benzothiazol-2-yl)benzamide

IUPAC name

2-bromo-N-(6-methoxy-13-benzothiazol-2-yl)benzamide

SMILES

COc(cc1)cc2c1nc(NC(c(cccc1)c1Br)=O)s2

InChI

InChI=1S/C15H11BrN2O2S/c1-20-9-6-7-12-13(8-9)21-15(17-12)18-14(19)10-4-2-3-5-11(10)16/h2-8H,1H3,(H,17,18,19)

InChI Key

YTWVZHPPGFOHND-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD00857263

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

363.23

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

4.256

Distribution Coefficient, logD

4.249

Water Solubility, LogSw

-4.44

Polar Surface Area

40.635

Acid Dissociation Constant (pKa)

9.18

Base Dissociation Constant (pKb)

0.76

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

6.70

Y030-5022 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-Aging Library (44940 compounds)

Anti-infective Library (19449 compounds)

Anticancer Library (62698 compounds)

Antiviral Annotated Library (21441 compounds)

Antiviral Library (67538 compounds)

Human Receptors Annotated Library (5376 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Voltage-Gated Ion Channel-Targeted Library (4740 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Infections
  • Immune system
  • animal
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Nervous system
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • Kinases
  • Ion Channels
  • Kinases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with Y030-5022 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y030-5022?
Check Price and Availability of Y030-5022, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y030-5022 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y030-5022
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y030-5022
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y030-5022 available by request